Market Overview:
Natamycin is a natural antibiotic produced by the bacterium Streptomyces natalensis. It is used as a food preservative and has been approved for use in many countries. Natamycin 50% and natamycin 95% are the two types of natamycin available in the market. The food industry is the major application segment for natamycin, followed by medical applications. North America, Latin America, Europe, Asia Pacific and Middle East & Africa are the regional markets for natamycin.
Product Definition:
Natamycin is a macrolide antibiotic produced by the bacterium Streptomyces natalensis. It is used as a preservative in food and as an antibiotic in eye drops and other topical medications. Natamycin inhibits fungal growth, making it a common additive to food products that are susceptible to fungus, such as cheese and bread.
Natamycin 50%:
It is a semi-synthetic aminoglycoside antibiotic used to treat bacterial infections. It works by inhibiting the action of bacteria by binding to the peptidoglycan cell wall, thus preventing the formation of new cells.
The product has been approved for use in humans and animals in several countries including U.S.
Natamycin 95%:
Natamycin ( Nat 95% ) is a semi-synthetic aminoglycoside antibiotic used to treat infections caused by susceptible gram-positive and gram-negative bacteria. It has the ability to inhibit bacterial protein synthesis, which leads to its effective action against multi drug resistant strains.
The product was first registered in Japan in 1970 and was approved for sale in Europe.
Application Insights:
The medical application of the drug accounted for the largest share in 2017. The growing prevalence of chronic diseases, such as tuberculosis, respiratory infections and skin infections is expected to drive demand for namcycline over the forecast period. In addition, increasing spending on R&D pertaining to new drugs and medicines is anticipated to fuel market growth over the coming years.
Food industry was one of the prominent applications that contributed significantly towards revenue generation in 2017 owing to rising awareness about hygiene among consumers regarding food safety. Furthermore, an increase in production capacities coupled with changing consumer preferences towards processed foods is expected to propel demand from this segment over next eight years or so.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to witness a CAGR of XX% over the forecast period, owing to increasing demand for meat products and rising prevalence of diseases such as cancer, diabetes, obesity, and arthritis among others. In addition, high adoption of processed food products is also driving the regional market growth.
Europe accounted for a significant share in terms of revenue generation in 2017 due to presence of major meat processing companies including JBS; Tyson Foods Inc.; National Foods; Cargill Inc.; and Cardinal Health in Europe that use natamycin extensively across their production processes are likely to drive product demand over the forecast period.
Growth Factors:
- Increasing demand for natamycin in food and beverage industry as a preservative to increase the shelf life of products.
- Rising demand for natamycin in personal care and cosmetics industry as an anti-fungal agent.
- Growing popularity of probiotics supplements which use natamycin as a key ingredient to improve gut health.
- Increasing research on the benefits of using natamycin in medical applications such as treating cancer, diabetes, and other diseases.
Scope Of The Report
Report Attributes
Report Details
Report Title
Natamycin Market Research Report
By Type
Natamycin 50%, Natamycin 95%
By Application
Food industry, Medical, Others
By Companies
Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Natamycin Market Report Segments:
The global Natamycin market is segmented on the basis of:
Types
Natamycin 50%, Natamycin 95%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Food industry, Medical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
Highlights of The Natamycin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Natamycin 50%
- Natamycin 95%
- By Application:
- Food industry
- Medical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Natamycin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Natamycin is a macrolide antibiotic that is used to treat a variety of infections, including pneumonia. It is available in pill form and can be taken by mouth or injected into the bloodstream. Natamycin works by killing bacteria cells.
Some of the major companies in the natamycin market are Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua, Zhengzhou New Frey, Chihon, Jiaozuo Joincare, Beijing Oriental Rada, Pucheng Lifecome.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Natamycin Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Natamycin Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Natamycin Market - Supply Chain
4.5. Global Natamycin Market Forecast
4.5.1. Natamycin Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Natamycin Market Size (000 Units) and Y-o-Y Growth
4.5.3. Natamycin Market Absolute $ Opportunity
5. Global Natamycin Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Natamycin Market Size and Volume Forecast by Type
5.3.1. Natamycin 50%
5.3.2. Natamycin 95%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Natamycin Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Natamycin Market Size and Volume Forecast by Application
6.3.1. Food industry
6.3.2. Medical
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Natamycin Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Natamycin Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Natamycin Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Natamycin Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Natamycin Demand Share Forecast, 2019-2026
9. North America Natamycin Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Natamycin Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Natamycin Market Size and Volume Forecast by Application
9.4.1. Food industry
9.4.2. Medical
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Natamycin Market Size and Volume Forecast by Type
9.7.1. Natamycin 50%
9.7.2. Natamycin 95%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Natamycin Demand Share Forecast, 2019-2026
10. Latin America Natamycin Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Natamycin Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Natamycin Market Size and Volume Forecast by Application
10.4.1. Food industry
10.4.2. Medical
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Natamycin Market Size and Volume Forecast by Type
10.7.1. Natamycin 50%
10.7.2. Natamycin 95%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Natamycin Demand Share Forecast, 2019-2026
11. Europe Natamycin Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Natamycin Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Natamycin Market Size and Volume Forecast by Application
11.4.1. Food industry
11.4.2. Medical
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Natamycin Market Size and Volume Forecast by Type
11.7.1. Natamycin 50%
11.7.2. Natamycin 95%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Natamycin Demand Share, 2019-2026
12. Asia Pacific Natamycin Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Natamycin Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Natamycin Market Size and Volume Forecast by Application
12.4.1. Food industry
12.4.2. Medical
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Natamycin Market Size and Volume Forecast by Type
12.7.1. Natamycin 50%
12.7.2. Natamycin 95%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Natamycin Demand Share, 2019-2026
13. Middle East & Africa Natamycin Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Natamycin Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Natamycin Market Size and Volume Forecast by Application
13.4.1. Food industry
13.4.2. Medical
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Natamycin Market Size and Volume Forecast by Type
13.7.1. Natamycin 50%
13.7.2. Natamycin 95%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Natamycin Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Natamycin Market: Market Share Analysis
14.2. Natamycin Distributors and Customers
14.3. Natamycin Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Danisco
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DSM
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. VGP
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Handary
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AMTECH BIOTECH
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Silver-Elephant
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lanzhou Weiri
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Langfang Meihua
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Zhengzhou New Frey
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Chihon
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Jiaozuo Joincare
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Beijing Oriental Rada
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Pucheng Lifecome
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook